836 related articles for article (PubMed ID: 37229456)
61. Gut microbiota and acute graft-versus-host disease.
Yoshioka K; Kakihana K; Doki N; Ohashi K
Pharmacol Res; 2017 Aug; 122():90-95. PubMed ID: 28576475
[TBL] [Abstract][Full Text] [Related]
62. Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review.
Dai Y; Shen Z; Khachatryan LG; Vadiyan DE; Karampoor S; Mirzaei R
Pathol Res Pract; 2023 Sep; 249():154740. PubMed ID: 37567034
[TBL] [Abstract][Full Text] [Related]
63. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.
Kaźmierczak-Siedlecka K; Daca A; Fic M; van de Wetering T; Folwarski M; Makarewicz W
Gut Microbes; 2020 Nov; 11(6):1518-1530. PubMed ID: 32453670
[TBL] [Abstract][Full Text] [Related]
64. Impacts of gut microbiota on gestational diabetes mellitus: a comprehensive review.
Huang L; Thonusin C; Chattipakorn N; Chattipakorn SC
Eur J Nutr; 2021 Aug; 60(5):2343-2360. PubMed ID: 33512587
[TBL] [Abstract][Full Text] [Related]
65. Gut microbiota and cardiac arrhythmia.
Fan H; Liu X; Ren Z; Fei X; Luo J; Yang X; Xue Y; Zhang F; Liang B
Front Cell Infect Microbiol; 2023; 13():1147687. PubMed ID: 37180433
[TBL] [Abstract][Full Text] [Related]
66. Anorexia nervosa and gut microbiome: implications for weight change and novel treatments.
Wei Y; Peng S; Lian C; Kang Q; Chen J
Expert Rev Gastroenterol Hepatol; 2022 Apr; 16(4):321-332. PubMed ID: 35303781
[TBL] [Abstract][Full Text] [Related]
67. Targeting the gut microbiota to treat alcoholic liver diseases: evidence and promises.
Leclercq S; de Timary P; Stärkel P
Acta Gastroenterol Belg; 2020; 83(4):616-621. PubMed ID: 33321019
[TBL] [Abstract][Full Text] [Related]
68. Application of Microbiome-Based Therapies in Chronic Respiratory Diseases.
Lee SH; Lee JH; Lee SW
J Microbiol; 2024 Mar; 62(3):201-216. PubMed ID: 38635003
[TBL] [Abstract][Full Text] [Related]
69. Restoration of dysbiotic human gut microbiome for homeostasis.
Dixit K; Chaudhari D; Dhotre D; Shouche Y; Saroj S
Life Sci; 2021 Aug; 278():119622. PubMed ID: 34015282
[TBL] [Abstract][Full Text] [Related]
70. Microbial Metabolites: Critical Regulators in NAFLD.
Dai X; Hou H; Zhang W; Liu T; Li Y; Wang S; Wang B; Cao H
Front Microbiol; 2020; 11():567654. PubMed ID: 33117316
[TBL] [Abstract][Full Text] [Related]
71. [The gut microbiota, a new cardiovascular risk factor?].
Chong-Nguyen C; Duboc H; Sokol H
Presse Med; 2017; 46(7-8 Pt 1):708-713. PubMed ID: 28756077
[TBL] [Abstract][Full Text] [Related]
72. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN MANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED CONTROLLED TRIALS.
Barengolts E
Endocr Pract; 2016 Oct; 22(10):1224-1234. PubMed ID: 27409822
[TBL] [Abstract][Full Text] [Related]
73. Crosstalk between the gut microbiota and postmenopausal osteoporosis: Mechanisms and applications.
Xu Q; Li D; Chen J; Yang J; Yan J; Xia Y; Zhang F; Wang X; Cao H
Int Immunopharmacol; 2022 Sep; 110():108998. PubMed ID: 35785728
[TBL] [Abstract][Full Text] [Related]
74. Gut microbiota and myocardial fibrosis.
Xu H; Yang F; Bao Z
Eur J Pharmacol; 2023 Feb; 940():175355. PubMed ID: 36309048
[TBL] [Abstract][Full Text] [Related]
75. Gut Microbiome and Polycystic Ovary Syndrome: Interplay of Associated Microbial-Metabolite Pathways and Therapeutic Strategies.
Babu A; Devi Rajeswari V; Ganesh V; Das S; Dhanasekaran S; Usha Rani G; Ramanathan G
Reprod Sci; 2024 Jun; 31(6):1508-1520. PubMed ID: 38228976
[TBL] [Abstract][Full Text] [Related]
76. Microbiota: A potential orchestrator of antidiabetic therapy.
Liu B; Zhang L; Yang H; Zheng H; Liao X
Front Endocrinol (Lausanne); 2023; 14():973624. PubMed ID: 36777348
[TBL] [Abstract][Full Text] [Related]
77. Prebiotics as a Tool for the Prevention and Treatment of Obesity and Diabetes: Classification and Ability to Modulate the Gut Microbiota.
Megur A; Daliri EB; Baltriukienė D; Burokas A
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682774
[TBL] [Abstract][Full Text] [Related]
78. Psoriasis: Interplay between dysbiosis and host immune system.
Kapoor B; Gulati M; Rani P; Gupta R
Autoimmun Rev; 2022 Nov; 21(11):103169. PubMed ID: 35964945
[TBL] [Abstract][Full Text] [Related]
79. Novel insights in the relationship of gut microbiota and coronary artery diseases.
Ramírez-Macías I; Orenes-Piñero E; Camelo-Castillo A; Rivera-Caravaca JM; López-García C; Marín F
Crit Rev Food Sci Nutr; 2022; 62(14):3738-3750. PubMed ID: 33399007
[TBL] [Abstract][Full Text] [Related]
80. Interaction between gut microbiome and cardiovascular disease.
Peng J; Xiao X; Hu M; Zhang X
Life Sci; 2018 Dec; 214():153-157. PubMed ID: 30385177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
